Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum Jürgen BeckmannUlrich HagemannIan C. K. Wong Special Article 30 August 2014 Pages: 743 - 759
Pharmacovigilance for a Revolving World: Prospects of Patient-Generated Data on the Internet G. Niklas Norén Editorial 06 August 2014 Pages: 761 - 764
Pharmacovigilance in China: Current Situation, Successes and Challenges Li ZhangLisa Y. L. WongIan C. K. Wong Leading Article 14 September 2014 Pages: 765 - 770
Restrictive Reimbursement Policies: Bias Implications for Claims-Based Drug Safety Studies Joshua J. Gagne Leading Article 04 September 2014 Pages: 771 - 776
Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art Rave HarpazAlison CallahanNigam H. Shah Leading Article 24 August 2014 Pages: 777 - 790
The Safety of Olanzapine in Young Children: A Systematic Review and Meta-Analysis Jacqueline FlankLillian SungL. Lee Dupuis Systematic Review 22 August 2014 Pages: 791 - 804
Comparison of Pregnancy and Lactation Labeling for Attention-Deficit Hyperactivity Disorder Drugs Marketed in Australia, the USA, Denmark, and the UK Pernille WarrerLise AagaardEbba Holme Hansen Original Research Article 12 August 2014 Pages: 805 - 813
Safety Profile of Dapagliflozin for Type 2 Diabetes: Pooled Analysis of Clinical Studies for Overall Safety and Rare Events Agata PtaszynskaKristina M. JohnssonJames F. List Original Research Article 06 August 2014 Pages: 815 - 829